Literature DB >> 12527111

Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy.

J L Griffin1, J C M Pole, J K Nicholson, P L Carmichael.   

Abstract

High resolution magic angle spinning (HRMAS) 1H NMR spectroscopy was used to metabolically characterise Ishikawa cells, a human cell line derived from endometrial adenocarcinoma. The spectra obtained had well-resolved resonances from the nucleotide derivatives of uridine and adenosine. Using a combination of diffusion- and relaxation-weighted spectroscopy, the cellular environment of key metabolites previously identified as related to cell growth was also investigated. As Ishikawa cells are hormone-responsive, the metabolic action of tamoxifen, a selective estrogen receptor modulator (SERM), was also investigated. Cells were exposed to 5, 1 and 0.1 microM tamoxifen. Using the statistical regression technique of prediction to latent structures by partial least squares, a predictive model was built modelling the metabolic profile of the cells against exposure to tamoxifen. These spectral changes were characterised by increased resonance intensities from ethanolamine (3.26 ppm), glucose (3.34-3.94 ppm), glutamate (2.14, 2.32 ppm), tyrosine (7.24 ppm), uridine (7.85 ppm) and adenosine (8.20 ppm), and a relative decrease in contributions from myo-inositol resonances (3.30, 3.62, 3.55 ppm). The nucleotide changes suggest that tamoxifen affects RNA transcription, while the changes in ethanolamine and myo-inositol concentrations are indicative of cell membrane turnover.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527111     DOI: 10.1016/s0304-4165(02)00475-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Metabolic profiles to define the genome: can we hear the phenotypes?

Authors:  Julian L Griffin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

2.  Pre-analytic Considerations for Mass Spectrometry-Based Untargeted Metabolomics Data.

Authors:  Dominik Reinhold; Harrison Pielke-Lombardo; Sean Jacobson; Debashis Ghosh; Katerina Kechris
Journal:  Methods Mol Biol       Date:  2019

3.  Use of nuclear magnetic resonance-based metabolomics in detecting drug resistance in cancer.

Authors:  Andrea L Merz; Natalie J Serkova
Journal:  Biomark Med       Date:  2009-06-01       Impact factor: 2.851

Review 4.  Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models.

Authors:  Eva Kaebisch; Taylor L Fuss; Lindsey A Vandergrift; Karin Toews; Piet Habbel; Leo L Cheng
Journal:  NMR Biomed       Date:  2017-03-16       Impact factor: 4.044

Review 5.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 6.  Metabolomics of neural progenitor cells: a novel approach to biomarker discovery.

Authors:  M Maletić-Savatić; L K Vingara; L N Manganas; Y Li; S Zhang; A Sierra; R Hazel; D Smith; M E Wagshul; F Henn; L Krupp; G Enikolopov; H Benveniste; P M Djurić; I Pelczer
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2008-11-06

7.  1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug.

Authors:  Martina Vermathen; Lydia E H Paul; Gaëlle Diserens; Peter Vermathen; Julien Furrer
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

8.  Exploring abiotic stress on asynchronous protein metabolism in single kernels of wheat studied by NMR spectroscopy and chemometrics.

Authors:  H Winning; N Viereck; B Wollenweber; F H Larsen; S Jacobsen; I Søndergaard; S B Engelsen
Journal:  J Exp Bot       Date:  2009       Impact factor: 6.992

9.  Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines.

Authors:  Stefano Tiziani; Alessia Lodi; Farhat L Khanim; Mark R Viant; Christopher M Bunce; Ulrich L Günther
Journal:  PLoS One       Date:  2009-01-22       Impact factor: 3.240

10.  Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.

Authors:  Mariona Jové; Sònia Gatius; Andree Yeramian; Manuel Portero-Otin; Núria Eritja; Maria Santacana; Eva Colas; Maria Ruiz; Reinald Pamplona; Xavier Matias-Guiu
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.